FDA Gives Speedy Approval to Brentuximab for Peripheral T-Cell Lymphoma
Report Finds Wide Variation in Average Cost of Healthcare Across the US
FDA Proposes Tighter Regulations as Youth e-Cigarette Smoking Skyrockets
CD47 Antibody With Rituximab Produces Durable Response in R/R Lymphoma